Directory
>
Sam Kay Cfa
Sam Kay Cfa
Executive Director - Business Development & Corporate Strategy | Mersana Therapeutics
Boston, Massachusetts, United States
Sam Kay Cfa
Summary
Sam Kay is an accomplished executive in business development and corporate strategy, with extensive experience in the biotechnology and pharmaceutical industries. With a strong analytical background, he has successfully led numerous high-value partnerships and strategic initiatives, contributing to significant acquisitions and collaborations. Sam's expertise spans across various therapeutic areas, particularly oncology, where he has demonstrated a keen ability to drive growth through innovative strategies. He is recognized for his leadership in navigating complex market dynamics and fostering relationships with key stakeholders. A graduate of McGill University, he combines scientific knowledge with business acumen, making him a valuable asset in any organization. Sam's awards highlight his commitment to excellence and his impact on the industry. His adaptability and learning agility enable him to thrive in fast-paced environments, while his dedication to advancing healthcare solutions remains a driving force in his career.
Sam Kay Cfa
Work Experience
Executive Director - Business Development & Corporate Strategy at
Mersana Therapeutics
December 2020 - Present
Director - Business Development & Portfolio Strategy at
Immunomedics
October 2018 - December 2020
Associate Director - US Oncology Strategy & Operations at
Novartis
January 2017 - October 2018
Associate Director - Oncology Global Business Analysis at
Novartis
August 2014 - December 2016
Market Intelligence - Business Analyst at
Novartis
September 2011 - August 2014
Analyst, Market Intelligence at
Labopharm
January 2010 - January 2011
Internship - Investment Researcher at
Aegis Capital LLC
January 2010 - January 2010
Project Manager / Market Intelligence Analyst at
Akela Pharma
January 2007 - January 2009
Sam Kay Cfa
Education
McGill University, Bachelor Of Science
January 2004 - January 2007
Frequently Asked Questions about Sam Kay Cfa
What is Sam Kay Cfa email address?
Sam Kay Cfa's primary email address is ****@immunomedics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sam Kay Cfa work for?
Sam Kay Cfa is a Executive Director - Business Development & Corporate Strategy at Mersana Therapeutics, a company specializing in Commercial physical research.
Where Sam Kay Cfa graduated from?
Sam Kay Cfa holds a degree in Microbiology & Immunology, Neuroscience from McGill University.
How can I directly contact Sam Kay Cfa?
To contact Sam Kay Cfa directly, you can use the email address ****@immunomedics.com. Complete contact information is available upon registration with Muraena.
Who is Sam Kay Cfa?
Sam Kay is an accomplished executive in business development and corporate strategy, with extensive experience in the biotechnology and pharmaceutical industries. With a strong analytical background, he has successfully led numerous high-value partnerships and strategic initiatives, contributing to significant acquisitions and collaborations. Sam's expertise spans across various therapeutic areas, particularly oncology, where he has demonstrated a keen ability to drive growth through innovative strategies. He is recognized for his leadership in navigating complex market dynamics and fostering relationships with key stakeholders. A graduate of McGill University, he combines scientific knowledge with business acumen, making him a valuable asset in any organization. Sam's awards highlight his commitment to excellence and his impact on the industry. His adaptability and learning agility enable him to thrive in fast-paced environments, while his dedication to advancing healthcare solutions remains a driving force in his career.
Sam`s contact details
****@immunomedics.com
****@mersana.com
Colleagues
VP, Information, Technology and Risk
SVP, Chief Legal Officer
Executive Director, Supplier Quality Drug Substance
Vice President, Clinical Quality Assurance
Executive Director, Sterile Drug Products
Chief Manufacturing Officer
Chief Development Officer
Vice President of Quality, Manufacturing
Executive Director Clinical Operations
Chairperson of the Board